By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Parents find bathing a newborn to be both a treasure and a little daunting. It is possible to form a distraction-free bond with a baby when they are enjoying the thrill of feeling warm water on their skin.
Newborn infants don’t typically get messy. When the umbilical cord stump is still attached, sponge showers are typically sufficient to keep a baby clean.
For newborn babies, an oil massage provides a number of advantages. Applying or lightly massaging the baby’s skin and muscles with an oil, such as coconut, sesame, or olive oil, can tone up their muscles and skin. Oil is absorbed from the newborn’s delicate, velvety skin and serves as an additional feed.
Another common misconception is that these infants need fewer feeds since the absorbed oil provides them with nutrition.
The India baby bath care market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.
Sebamed introduces a brand-new marketing campaign for their line of baby care products called “Pratham Snan Se”—Perfect start from the very first bath.
The brand continues to share fresh information on the pH of skin from birth and emphasizes the value of using Sebamed products with pH 5.5 straight away in a manner similar to its past shampoo and bathing bar advertisements.
Situational humor is used in the “Pratham Snan Se” campaign to emphasize the idea that modern mothers will only choose the greatest items for their children.
In every market in which they compete, they work to establish a new story, and the safety and superiority of their products have been independently verified.
One of the main growth drivers for us and this campaign is our baby care offering. USV Private Limited markets Sebamed products in India.
With over 60 years of exemplary history and a solid set of core values, USV Private Limited is a prominent pharmaceutical company that holds positions of leadership in India’s cardiac and diabetic therapeutic markets.
